California State Teachers Retirement System Sells 7,900 Shares of Luminex Corp. (LMNX)
California State Teachers Retirement System lowered its stake in Luminex Corp. (NASDAQ:LMNX) by 8.7% during the second quarter, Holdings Channel reports. The fund owned 83,277 shares of the company’s stock after selling 7,900 shares during the period. California State Teachers Retirement System owned 0.20% of Luminex Corp. worth $1,685,000 as of its most recent SEC filing.
Other institutional investors also recently added to or reduced their stakes in the company. BlackRock Fund Advisors increased its position in Luminex Corp. by 1.6% in the first quarter. BlackRock Fund Advisors now owns 3,017,364 shares of the company’s stock valued at $58,537,000 after buying an additional 46,200 shares during the last quarter. Prudential Financial Inc. increased its position in Luminex Corp. by 5.3% in the first quarter. Prudential Financial Inc. now owns 93,840 shares of the company’s stock valued at $1,820,000 after buying an additional 4,700 shares during the last quarter. Aperio Group LLC increased its position in Luminex Corp. by 36.6% in the first quarter. Aperio Group LLC now owns 13,048 shares of the company’s stock valued at $253,000 after buying an additional 3,499 shares during the last quarter. Renaissance Technologies LLC increased its position in Luminex Corp. by 19.1% in the first quarter. Renaissance Technologies LLC now owns 1,007,840 shares of the company’s stock valued at $19,552,000 after buying an additional 161,800 shares during the last quarter. Finally, BlackRock Group LTD increased its position in Luminex Corp. by 4.6% in the first quarter. BlackRock Group LTD now owns 64,271 shares of the company’s stock valued at $1,247,000 after buying an additional 2,828 shares during the last quarter. 80.50% of the stock is owned by institutional investors.
Luminex Corp. (NASDAQ:LMNX) traded down 0.46% during midday trading on Friday, reaching $21.86. The company’s stock had a trading volume of 282,132 shares. The firm has a market capitalization of $951.96 million, a price-to-earnings ratio of 22.82 and a beta of 0.45. Luminex Corp. has a 12 month low of $16.16 and a 12 month high of $23.75. The stock’s 50-day moving average price is $21.54 and its 200-day moving average price is $20.50.
Luminex Corp. (NASDAQ:LMNX) last released its earnings results on Thursday, July 28th. The company reported $0.33 earnings per share for the quarter, topping analysts’ consensus estimates of $0.15 by $0.18. The firm earned $64.20 million during the quarter, compared to the consensus estimate of $61.20 million. Luminex Corp. had a return on equity of 13.65% and a net margin of 16.60%. The firm’s revenue for the quarter was up 8.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.27 earnings per share. Analysts predict that Luminex Corp. will post $0.63 EPS for the current year.
Several equities analysts have weighed in on LMNX shares. Zacks Investment Research downgraded Luminex Corp. from a “buy” rating to a “hold” rating in a research report on Monday, July 4th. JPMorgan Chase & Co. raised Luminex Corp. from an “underweight” rating to a “neutral” rating and lifted their price objective for the company from $18.00 to $22.00 in a research report on Thursday, August 18th. Finally, Jefferies Group lifted their price objective on Luminex Corp. from $21.00 to $23.00 and gave the company a “hold” rating in a research report on Thursday, July 28th. Six research analysts have rated the stock with a hold rating, The stock currently has a consensus rating of “Hold” and an average price target of $22.20.
About Luminex Corp.
Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company has a range of instruments using its xMAP technology, including its LUMINEX 100/200 systems offer 100-plex testing; the Company’s FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry.
Want to see what other hedge funds are holding LMNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Luminex Corp. (NASDAQ:LMNX).
Receive News & Ratings for Luminex Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luminex Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.